Patent 10314525 was granted and assigned to Dexcom on June, 2019 by the United States Patent and Trademark Office.
The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.